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Summary  Many  studies  have  shown  that  the  toxic  effects  of  local  antibiotics  on
bone  and  cartilage  limit  orthopedic  surgeons.  In  this  study,  we  evaluated  three
antibacterial  agents  used  locally  to  treat  highly  mortal  and  morbid  diseases  in  the
ﬁeld  of  orthopedics,  such  as  septic  arthritis.  Are  vancomycin,  teicoplanin,  and  line-Toxicity; zolid,  which  are  archenemies  of  Staphylococcus  aureus,  really  toxic  to  chondrocytes?
The  purpose  of  the  study  was  to  investigate  the  effects  of  antibiotics,  which  are  usedVancomycin
against  S.  aureus, on  human  chondrocytes  in  vitro.
Primary  cell  cultures  obtained  from  gonarthrosis  patients  were  divided  into  two
main  groups.  One  of  these  groups  was  designated  as  the  control  chondrocyte  culture.
The  other  group  was  divided  into  three  subgroups,  and  each  group  was  exposed
 Level of Evidence: Level I, in vitro clinical research study.
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Introduction
Side  effects  and  adverse  reactions  occur  frequently
during systemic  antibiotic  therapies  [1,2].  The  pro-
longed and  high-dose  administration  of  antibiotics
required to  treat  septic  arthritis  and  osteomyeli-
tis results  in  side-effect  proﬁles  that  also  involve
toxicity problems  [1,3—5]. To  avoid  such  delete-
rious effects,  local  antibiotics  are  often  utilized,
especially intra-operatively  [6—11]. In  orthope-
dics, placing  antibiotic-impregnated  Spongostan  or
gels/grafts in  various  forms  into  infected  regions
has been  found  useful  to  ﬁght  infection  or  to  act
as a  prophylactic  [2,3,7—9].  However,  the  toxicity
of these  local  antibiotics  has  been  discussed  in  the
literature  [1].  Additionally,  reports  indicating  local
osteotoxic  and  chondrotoxic  effects  have  imposed
some  limitations  on  orthopedic  surgeons  [1,10],
especially  with  regard  to  certain  procedures  involv-
ing open  surgeries,  such  as  intra-articular  fracture
surgery  and  multiple  ligament  knee  injuries.  In  such
cases, both  prophylaxis  and  the  use  of  antibiotic
therapy may  be  helpful  [12,13].  In  the  present
study, vancomycin  (VCM)  [6], known  to  be  chondro-
toxic,  and  its  alternatives  teicoplanin  (TEIC)  and
linezolid  (LZD),  commonly  used  against  Staphylo-
coccus aureus,  the  most  common  cause  of  septic
arthritis, were  speciﬁcally  chosen  due  to  their  com-
mon use  in  orthopedics.  The  chondrotoxicity  of
these three  antibiotics  are  investigated  in  human
primary  chondrocyte  cultures.
Materials and methods
Prior  to  the  present  research,  approval  from  the
Namik  Kemal  University  Medical  Faculty  Ethics
Committee (Date:  25/12/2014;  Number:  127)  and
the participant  written  informed  consents  were
obtained. Primary  chondrocyte  cultures  consisted
e
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or  linezolid.  Cell  culture  samples  were  characterized  by
g  incubation  with  the  three  different  antibiotics.  Before
dministered,  the  cultures  were  subjected  to  inverted
 electron  microscopy.  The  number  of  live  cells  and  the
tored  with  the  MTT-assay.
 teicoplanin,  and  linezolid  do  not  have  chondrotoxic
 linezolid  had  no  chondrotoxic  activity  during  in  vitro  cul-
ment  that  these  agents  can  safely  be  used  in  orthopedic
ethicillin-resistant  S.  aureus  agents.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
f  surgically  harvested  osteochondral  tissues  from
onarthrosis  patients  undergoing  routine  total  knee
rthroplasty,  (n  =  6);  VCM,  TEIC,  and  LZD  agents
ere added,  and  cell  viability,  toxicity,  and  prolif-
ration  analyses  were  conducted  at  baseline  (0  h),
efore the  application  of  antibiotics,  and  after  24  h.
urface morphologies  and  the  extracellular  matrix
ere examined  using  inverted  and  environmental
canning electron  microscopes  (ESEM).  To  mini-
ize measurement  and  analysis  errors,  the  same
esearcher  performed  the  analyses  both  during
nd after  the  primary  chondrocyte  culturing.  The
esearchers  conducting  the  analyses  were  blinded
o the  type  of  drug  used  and  the  experimen-
al setup.  All  experiments  were  conducted  three
imes.
aterials
ollagenase  type  II  enzyme  (1  mg/mL,  Invitrogen
orporation); Hank’s  Balanced  Salt  Solution  (HBSS-
X, 14025,  Gibco);  penicillin-streptomycin  with
etal bovine  serum  (FBS);  and  Dulbecco’s  Modi-
ed Eagle’s  Medium  (DMEM)  (1000  mg  glucose/L)
ere obtained  from  Sigma  Chemical,  St.  Louis,
SA. Sodium  dodecyl  sulfate  (SDS)  (10%  L4522),
nsulin—transferrin—selenium  (ITS)  premix,  and
PMI-1640  were  obtained  from  Sigma—Aldrich
mbH, Germany.  The  MTT  Kit  was  a  Vybrant  MTT
ell Proliferation  Assay  (Catalog  /=  V-13154)  by
ell Biolabs  Inc.,  USA.  A  laminar  ﬂow  cabinet  (Air
low-NUVE/NF-800  R)  and  an  incubator  (NUVE,
6750) were  obtained  in  Ankara,  Turkey.  An  Olym-
us CKX41  inverted  microscope  was  used  and  the
mages were  recorded  using  an  Olympus  cell  soft
maging  system  program.  A  Mindray  MR  96A  (PRC)
nzyme-linked  immunosorbent  assay  (ELISA)  device
easured  viability,  cytotoxicity,  and  proliferation
ith a commercial  kit.  This  study  used  a Quanta  250
EG (Fei  Company,  Hillsboro,  Oregon,  USA)  ESEM.
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are  the  leading  drugs  against  Staphylococcus  aureu
ethods
atient  selection  criteria
steochondral  tissues  to  be  used  in  the  primary
hondrocyte culture  were  obtained  from  patients
ho  were  not  allergic  to  VCM,  LZD,  or  TEIC.
dditionally,  the  study  excluded  patients  with
arkinson’s disease  who  had  been  treated  with
onoamine  oxidase  inhibitors,  such  as  rasagiline,
elegiline,  or  moclobemide,  in  the  previous  14  days,
s well  as  patients  receiving  antidepressant  drugs,
o prevent  drug  interaction.  Linezolid  is  also  one
 monoamine  oxidase  inhibitor  itself.  Therefore,
t can  cause  an  increase  in  the  adrenergic  pressor
esponse.
reparation of  the  drugs
ain stock  solutions  were  freshly  prepared  by  dis-
olving VCM  and  TEIC  in  1000  and  400  mg  DMEM
ulture media,  respectively,  in  a  ﬂow  cabin.  The
ZD was  prepared  using  a  readymade  300  mL  solu-
ion with  a  concentration  of  2 mg/mL.  Next,  these
ain stock  solutions  were  coded  to  keep  the
esearchers blinded  to  the  treatment  before  being
ransferred  to  dark-brown  bottles.
Final concentrations  of  the  drugs  administered  to
he chondrocyte  cultures  were  determined  in  rela-
ion to  their  minimal  bactericidal  concentrations
MBC). The  practiced  MBC  reference  values  were
6 mg/L  for  VCM,  64  mg/L  for  TEIC,  and  32  mg/L  for
ZD [14].
btaining  the  primary  chondrocyte  culture
he study  included  tissues  obtained  from
onarthrosis patients  whose  medical  and  con-
ervative  treatments  had  failed  and  who  were
ndergoing total  knee  arthroplasty  surgery  [n  =  6;
ean age  65  years  (59—71);  Stage  4  gonarthrosis].
atient informed  consent  was  obtained.  Osteo-
hondral tissues  were  resected  from  the  distal
emur and  the  proximal  tibia,  which  are  routinely
ut away  during  total  knee  arthroplasty.  Standard
uman primary  chondrocyte  cultures  were  then
erformed  [15—18].
The cells  were  counted  on  a  Thoma  counting
hamber in  trypan  blue  and  placed  in  a  24-well
late with  125  ×  103 cells  in  each  well;  they  were
hen stored  in  an  incubator  for  48  h.  At  the  end  of
his time  period,  the  drugs  were  introduced  into  the
ell cultures,  which  became  conﬂuent  and  stuck  to
he bottom.xposure  of  the  drugs  into  the  cultures
he control  group,  named  Group  I,  consisted  of
ure primary  chondrocyte  cultures.  Groups  II,  III,
nd IV  consisted  of  primary  chondrocyte  cultures
h
t
i
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hat  contained  VCM,  LZD,  and  TEIC,  respectively.
n additional  sample  was  kept  aside  from  both  the
tudy and  control  groups  for  MTT-ELISA  and  ESEM
nalyses.
nalyses
ells that  displayed  chondrotoxic  activity  and  stuck
o the  inner  surface  of  the  ﬂasks  were  exam-
ned under  an  inverted  microscope,  and  the  micro
mages  were  recorded.  Inverted  microscopy,  MTT-
LISA cell  viability  and  toxicity,  and  ESEM  analyses
ere  performed  on  Group  I at  both  0  and  24  h.  The
ame analyses  were  performed  on  Groups  II,  III,  and
V at  0  and  24  h after  introducing  the  antibacterial
gents.
SEM analysis.  In  this  stage,  the  surface  topogra-
hy and  the  extracellular  matrix  structures  of  the
hondrocytes  were  examined,  and  the  cell-culture
ontents of  the  wells  were  expelled  using  gun  pipet-
ors. A  2.5%  glutaraldehyde  solution  composed  of
7.5 mL  cacodylate  buffer  and  2.5  mL  glutaralde-
yde was  then  added  to  the  wells  to  cover  the
amples. The  glutaraldehyde  solution  was  removed
rom  the  samples  using  a  pipette  gun  and  kept  at
oom temperature  for  2  h.  The  samples  were  then
ashed three  times  with  cacodylate  buffer.  Follow-
ng the  last  washing,  the  samples  were  covered  with
acodylate  buffer  and  kept  at  4 ◦C  until  analysis.
he MTT  cell  viability,  toxicity,  and  proliferation
ssays. Viability  tests  were  performed  using  a
ommercial  MTT  kit  (3-[4,5-dimethylthiazol-2-yl]-
,5-diphenyltetrazolium  bromide  (MW  = 414)  and
ollowing  the  manufacturer’s  instructions.  The  kit
orks as  follows:  mitochondrial  dehydrogenase
nzymes cleave  to  the  tetrazolium  ring,  yield-
ng blue  formazan  crystals,  which  do  not  occur
n dead  cells.  A  12  mM  MTT  stock  solution  was
repared by  dissolving  5  mg  MTT  in  sterile  phos-
hate buffer  saline.  The  antibiotic  medium  was
emoved  from  the  culture  medium  and  the  MTT
edium was  added  to  reach  a ﬁnal  concentra-
ion of 10%  (v/v).  This  mixture  was  incubated  at
7 ◦C  for  2  h.  At  the  end  of  the  incubation  period,
00 L  DMSO  were  added  as  a solvent  and  the  mix-
ure was  incubated  again  at  37 ◦C  for  10  min.  For
ach sample,  spectrophotometry  was  performed  at
40 nm  to  measure  the  absorbance.  The  project
oordinator transcribed  letter  labels  designated  for
ach sample.  The  vitality  of  the  control  group  was
ssumed  to  be  100%  before  the  transfer  of  the
ntibiotics (0  h)  to  the  culture  medium.  Twenty-four
ours after  the  administration  of  the  antibiotics,
he viability  absorbance  of  the  cells  was  recorded
n nanometers.  Proliferation  analyses  for  24—36  h
ere then  recorded.
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ondrocytes  at  0  and  24  h  in  the  control  group.
An evaluation of the ESEM analysis
Healthy  cells  and  extracellular  structures  were  seen
in the  morphological  evaluations  of  the  chondro-
cyte surfaces  before  antibiotic  exposure  (Fig.  4).
ESEM images  after  24  h of  antibiotic  exposure  sup-
port the  results  of  the  MTT-ELISA  viability,  toxicity,
and MTT-proliferation  data  analyses  as  well  as  the
invert images  (Fig.  5).  Healthy  chondrocytes  and
extracellular  matrices,  which  were  the  markers  of
chondroblastic  activity,  and  natural  surface  charac-
teristics  were  visible  in  the  images  from  all  of  the
groups.
Table  1  Cartilage  cells  growth  assessed  by  the  MTT
viability,  toxicity,  and  proliferation  assays  (540  nm)
after  exposure  to  three  different  antibiotics.
Groups  Mean  ±  SD  pa
MTT  cell  viability  and  toxicities
Control  of  VCM  0.28200  ±  0.01699
VCM  0.2735  ±  0.0594  0.743
Control  of  TEIC  0.2240  ±  0.0288
TEIC  0.2362  ±  0.0752  0.719
Control  of  LZD  0.2653  ±  0.0482
LZD  0.2705  ±  0.0540  0.865
MTT  cell  proliferation  test
VCM  107.4  ±  35.5Ab
TEIC  105.8  ±  28.3AbFigure  1  Invert  microscopy  images  of  ch
Statistical  analysis.  Cell  numbers  and  prolifera-
tion results,  along  with  Minitab  R15  software,  were
used to  analyze  the  data.  Each  drug  was  com-
pared with  its  own  control  group  using  the  variance
analysis, and  the  proliferation  data  were  analyzed
using  Tukey’s  Method  (with  95.0%  conﬁdence  inter-
vals).  The  statistical  signiﬁcance  level  was  set  at
 ˛ <  0.05.
Findings
Analysis of inverted microscopy results
Images  of  proliferated  healthy  chondrocytes
(91—99%)  in  the  control  group,  which  did  not
receive antibiotics  (Fig.  1).
The statistical evaluation of the effects of
the agents on chondrocytes via MTT
ELISA/MTT-proliferation assays
The  alive  cell  counts  in  all  of  the  groups  that
received antibiotics  were  similar  with  respect  to
the control  groups  at  24  h.  All  three  antibiotics  con-
tinued to  proliferate  in  the  36  h  of  test  that  began
at the  end  of  24th  hour  (Fig.  2).The 24  h  viability  and  36  h  proliferation  test
results showed  that  there  was  no  statically  differ-
ence  between  the  control  groups  and  the  groups
that received  antibiotics.  All  three  agents  were  not
toxic to  chondrocytes  (Table  1  and  Fig.  3).
0.914
LZD  101.63  ±  2.08Ab
a Analysis of variance test.
b Grouping information using Tukey’s Method and 95.0%
conﬁdence.
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iscussion
rthopedic  infections,  which  occasionally  jeopar-
ize the  outcome  of  the  surgery,  usually  require
ong-term antibiotic  treatments.  This  molecular
tudy investigated  the  cytotoxicity  of  VCM,  TEIC,
nd LZD  in  human  primary  chondrocyte  cultures.
hese agents  were  selected  because  they  can
[
i
j
a
Figure  3  The  absorbance  of  the  live  cell  cou h  (the  24th  hour  proliferation  test)  of  exposure  to  VCM,
e  administered  locally  and  systemically  to  treat
ethicillin-resistant  S.  aureus  (MRSA),  one  of  the
eading causes  of  orthopedic  infections.
Earlier studies  claimed  that  VCM  is chondrotoxic6]. In addition  to  its  systemic  use,  it  is  also  admin-
stered  locally  to  joints  [3]. Studies  comparing
oint and  serum  levels  following  the  intra-articular
nd parenteral  administration  of  VCM  concluded
nt  after  MTT-ELISA  analyses  in  all  groups.
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ces  i
[
r
c
c
c
cFigure  4  Morphological  evaluations  of  chondrocyte  surfa
that  intra-articular  administration  is  more  effec-
tive [19].  An  in  vivo  study  using  a  murine  bacterial
arthritis model  reported  that  VCM  and  LZD  can
safely  treat  MRSA  based  on  the  ﬁndings  that  reduc-
ing inﬂammatory  cytokines  in  the  group  treated
with VCM  and  LZD  led  to  decreased  accumulated
neutrophils  [20].Previous  cytotoxicity  studies  investigated  the
chondrotoxicity  of  not  only  various  antibacterial
agents of  the  glycopeptide  group  but  also  other
antibiotic agents,  such  as  the  quinolone  group
t
c
d
c
Figure  5  ESEM  images  at  the  24th  hour  after  the  administran  the  control  group  (ESEM  images  at  the  0  and  24th  hour.
21—23]. These  studies  examined  the  antibacte-
ial agents  used  in  orthopedic  surgeries  and  the
hondrotoxicity  of  a wide  range  of  pharmaceuti-
al agents,  such  as  local  anesthetics,  opioids,  and
orticosteroids,  on  a  molecular  level  [18,24,25].
Previous  in  vitro  studies  reported  that  VCM
auses less  osteoclast  activity  compared  to
obramycin,  cefazolin,  and  gentamicin.  Moreover,
ell-line  comparisons  showed  that  VCM  in  125  g/mL
oses is  toxic  to  osteoblast-  and  chondroblast-like
ells [1,6,26,27].
tion  of  antibiotics  in  primary  human  chondrocytes.
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Antoci  et  al.  investigated  the  chondrotoxicity  of
he glycopeptide  group  in  cell  lines  and  observed
CM to  be  chondrotoxic.  They  investigated  cyto-
oxicity  using  a  lactate  dehydrogenase  (LDH)  assay
6].  However,  the  LDH  assay  was  developed  as
 guide  when  the  direct  isolation  of  cells  is  not
chieved in  high-density  attached  cells.  Therefore,
he metabolite  level  is  measured  by  the  amount
f LDH  released  into  the  cell-culture  supernatant
nd taken  as  the  quantitative  value  for  the  loss
f live  cells.  In  other  words,  the  measurements
re not  performed  directly  in  cells  but  through
he reduction  of  enzymes  released  by  cells  in  the
edium.  The  data  would  have  been  more  robust
f metabolic  activity  and  DNA  synthesis,  which  are
sed in  a  single-course  culture  method,  had  been
sed instead  of  spectrophotometric  analysis  of  the
eduction  from  pyruvate  to  lactate  [28,29].
The most  popular  cytotoxicity  analysis  per-
ormed in  single-course  cell  cultures  involves  the
olorimetric  measurement  of  cell  proliferation
sing MTT  tetrazolium  salt.  The  MTT  method  has
een in  use  since  1983  for  cell  proliferation,  viabil-
ty,  and  toxicity  identiﬁcation  [30,31].
This method  is  quite  sensitive  in  the  quantiﬁca-
ion of  cell  proliferation  and  cytotoxicity,  especially
n chemotherapeutic  drugs,  in  which  only  live  cells
ith metabolic  activity  reduce  tetrazolium  salt  to
olored and  insoluble  formazan.  Therefore,  this
ethod  identiﬁes  only  live  cells.  It  not  only  identi-
es cell  viability  and  cytotoxicity  but  also  identiﬁes
ell activation  and  proliferation.  Tetrazolium  salts
ave been  proven  in  the  literature  as  the  most  sen-
itive and  most  soluble  methods  for  accurate  cell
itality,  toxicity,  and  proliferation  analyses,  and
everal new  methods,  such  as  WST,  XTT,  MTS,  and
TT, have  been  developed  [28—32].
Toxicity  studies  are  generally  performed  on  tis-
ues from  animal  articular  cartilage.  Obviously,
uman and  animal  tissues  have  different  sensi-
ivities,  and  thus,  results  may  be  different  and
isleading  [24]. The  use  of  a  single  type  of  cell  in
ell-line  systems,  the  lack  of  complicated  coordi-
ation  mechanisms  in  between  cells  and  the  micro
rame,  and  the  inhibition  of  interactions  with  the
xtracellular  matrix  structure  make  in  vitro  tests
roblematic  to  adopt  to  in  vivo  conditions,  in  terms
f compatibility  [33].  The  biggest  disadvantage  of
ell lines  is  that  they  do  not  carry  all  of  the  genotyp-
cal and  phenotypical  features  of  the  original  struc-
ure because  they  are  genetically  modiﬁed  [34].
In the  present  study,  human  primary  chondrocyte
ultures were  used  to  investigate  the  chondrotoxi-
ity of  three  agents.  Although  the  experiment  was
n vitro,  cell  cultures  were  not  obtained  from  ani-
als, and  a  cell  line  was  not  used.  Therefore,  weally  toxic  to  cartilage?  257
elieve  that  the  ﬁndings  are  robust.  Considering
he MBC  reference  values,  VCM  (16  mg/L),  TEIC
64 mg/L),  and  LZD  (32  mg/L)  have  no  chondrotoxic
ffects when  administered  locally.  The  present
tudy observed  that  these  antibacterial  agents,
hich  are  frequently  used  locally  in  orthopedic
nfections, are  not  toxic  to  cartilage,  especially  in
erms of  viability  and  proliferation.
onclusion
e  believe  that  these  antibacterial  agents,  which
howed  no  chondrotoxicity  in  either  a  cellular
imension or  on  a molecular  level,  can  safely
e locally  used  in  orthopedic  surgery,  especially
gainst MRSA  agents.  However,  this  is  only  an
n vitro  study.  Antibiotics  did  not  show  adverse
ffects on  cultured  chondrocytes  from  six  patients
n the  age  range  of  59—71  years.  We  cannot
onclude that  the  antibiotics  are  safe  in  vivo
n orthopedic  surgery.  The  evidence  supports  the
ypothesis  only,  and  it  does  not  disprove  the
ypothesis. In  an  extension  of  this  study,  the  effect
f the  antibiotics  on  cell  function  should  be  per-
ormed in  different  phases  of  growth  and  for
ariable lengths  of  exposure  time.  Further  in  vivo
olecular  studies  investigating  these  agents  com-
aratively  and  in  a cellular  dimension  with  larger
amples  are  warranted.
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